RANGAP1 and chronic myelogenous leukemia, BCR-ABL1 positive: Furthermore, the trend of inverse correlation between the expression level of RanGAP1 and miR-1301 was demonstrated in CML patients, and RanGAP1 protein downregulation or an increased miR-1301 level is beneficial for the sensitivity of IM to CML cells.